Showing results (841-850 of 2,005) with videos related to

Sort By:
Pageof 201
Journal of Occupational and Environmental Medicine|May 4, 1999
Identification of occupational cancer risks in British Columbia. Part I: Methodology, descriptive results, and analysis of cancer risks, by cigarette smoking categories of 15,463 incident cancer casesP R Band, J J Spinelli, W J Threlfall, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2003
Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgeryMichael J Yunes, Andrew C Neuschatz, Linda E Bornstein, et al.
Seminars in Oncology|April 1, 1992
Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycinD Osoba, P R Band, J M Connors, et al.
BMC Biology|August 14, 2013
Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitro evidenceIrena Manov, Mark Hirsh, Theodore C Iancu, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|September 3, 2011
Arriving by emergency medical services improves time to treatment endpoints for patients with severe sepsis or septic shockRoger A Band, David F Gaieski, Julie H Hylton, et al.
Frontiers in Human Neuroscience|March 1, 2012
Functional significance of the emotion-related late positive potentialStephen B R E Brown, Henk van Steenbergen, Guido P H Band, et al.
Cancer Research|November 3, 2001
CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expressionB Li, J Goyal, S Dhar, et al.
Journal of Immunological Methods|December 4, 2013
TaqManR proximity ligation technology for the detection of heterodimeric adhesion receptors on lymphocytesRenate Gehwolf, Elisabeth Band, Andrea Trost, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|February 5, 2013
Hybrid hard- and soft-modeling of spectrophotometric data for monitoring of ciprofloxacin and its main photodegradation products at different pH valuesMariela Razuc, Mariano Garrido, Yamile S Caro, et al.
Clinical Breast Cancer|December 11, 2012
High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancerYihong Wang, Joseph A Sparano, Susan Fineberg, et al.
Pageof 201